Product Information
NISOLDIPINE ER 8.5 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $3.7128 per EA under NDC 00378209601. Its NADAC has been published 445 times since Nov 28, 2013.
Strength
8.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378209601
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
NISOLDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA091001On Market Since
1/28/2011
Pharmacological Classes
Price Statistics
The NADAC for NISOLDIPINE ER 8.5 MG TABLET has been published 445 times since Nov 28, 2013, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7128 per EA |
|---|---|
| All-time high | $4.3777 (Aug 15, 2018) |
| All-time low | $2.7972 (Nov 20, 2024) |
| 52-week high | $3.7211 |
| 52-week low | $3.2656 |
| Median price | $3.6461 |
| Average price | $3.6325 |
| Largest weekly change | +21.0% (Dec 18, 2013) |
| Weeks tracked | 445 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the nisoldipine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NISOLDIPINE ER 8.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NISOLDIPINE ER 8.5 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $3.7128 per EA (NDC 00378209601), effective Apr 1, 2026.
How has the price of NISOLDIPINE ER 8.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NISOLDIPINE ER 8.5 MG TABLET has risen 10.2%. It has been tracked across 445 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NISOLDIPINE ER 8.5 MG TABLET?
Since Nov 28, 2013, the NADAC for NISOLDIPINE ER 8.5 MG TABLET has ranged from a low of $2.7972 (Nov 20, 2024) to a high of $4.3777 (Aug 15, 2018), with a median of $3.6461 per EA.
Are there cheaper alternatives to NISOLDIPINE ER 8.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NISOLDIPINE ER 8.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures NISOLDIPINE ER 8.5 MG TABLET?
NISOLDIPINE ER 8.5 MG TABLET (NDC 00378209601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification